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Abstmct Persistence of unique rabies virus variants in a diverse array of terrestrial carnivores and insectivorous bats makes rabies 
control in the US.  a complcx task The public health systcm in the U.S. ic effective in keeping human deaths near zcro each year in 
the face of cnzootic wildlife rabies, hut the annual cost of coexistence with the J k .  is high, exceeding $300 million. In addition, 
each year tens of thousands of people are impacted by anxiety, fear, and trauma associated with potential or actual rabies exposure to 
themselves and their domestic animals. Exclusion, proper storage and disposal of garbage, and removal of problem animals are often 
effective alternatives to address wildlife rabies threats at specific sites; however, oral rabies vaccination (ORV) is the only currently 
available technique that shows promise for wildlife rabies control on a broad geographic and species scale. In this paper, we discuss 
progress toward using ORV to contain specific terrestrial rabies vhs variants in the U.S. and planning towards coordinated national 
efforts to explore the elimination of terrestrial variants of rabies vhs in the U.S. 
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INTRODUCllON Anxiety, fear, and trauma are examples of less easily 
Rabies is one of the oldest recorded infectious quantifiable impacts to humans associated with rabies 
diseases. It is an acute, fatal encephalitis caused by a threats to people and their pets and livestock (Meltzer and 
virus that is almost always transmitted by the bite of a Rupprecht 1998 a, b; McQuiston et al. 2001). 
rabid animal. Worldwide, rabies is estimated to cause Rabies viruses occur in the wild as unique variants 
50,000 to 70,000 human deaths annually (Meslin et al. adapted to specific species or geographic areas occupied 
1994). However, human rabies deaths in the U.S. and by a reservoir species (Smith et al. 1992) (Figure 1). The 
other developed countries annually approach zero as the most frequently reported species with rabies in the U.S. 
result of effective, integrated public health programs that are the raccoon (Procyon lotor) and skunk (primarily 
rely on public health education, rabies surveillance, case striped skunks, Mephitis mephitis) (Figure 2). 
investigation, efficient and accurate laboratory diagnosis, Insectivorous bats (Chiroptera spp.); arctic fox (Alopen 
pet vaccination programs, and safe and effective post- lagopus), red fox (Vulpes vulpes), and gray fox (Urocyon 
exposure prophylaxis. cinereoargenreus); and coyote (Canis latrans) are also 
During the early 19605, wild mammals emerged as important reservoirs for the vim, as is the small Indian 
the mast frequently reported animals infected with rabies mongoose (Herpestes auropunctatus) in Puerto Rico 
in the U.S., replacing the domestic dog as the dominant (Krebs et al. 2000). Although "spillover" of the virus has 
reservoirs for the v i m  w e b s  et al. m 1 ) .  For the past been reported in several mammalian taxa, including 
decade or more, wildl i fe-prhdy terrestrial carnivores rodents and deer (Childs et al. 1997, Krebs et al. m l ) ,  
and insectivorous bats-have accounted for at least 90 % additional reservoir species have not been documented 
of all animal rabies cases reported in the U.S. and Puerto (Smith 1996). 
Rico. The persistence of rabies virus among diverse Many challenges to contemporary rabies control 
carnivore and bat species greatly confounds rabies programs underscore the need for collaboration among 
control. multiple disciplines. These include: varying ecological, 
In spite of a public health strategy that is effective in behavioral and biological attributes of diverse wildlife 
preventing human rabies deaths in the U.S., the financial rabies reservoirs; the effective application of oral 
cost of coexistence with wildlife rabies is high, exceeding vaccines; environmental compliance; conducting 
$300 million annually (Fishbeii and R o b i n  1993). meaningful research to address existing data gaps; and 
Figure 1. Distribution of terrestrial reservoirs of rabies in the United States (adapted from CDC map in Krebs et al. 
2000). 
Wildlife Rabies Cares 
U.S. - 1999 (N-6,466) 
Figure 2. Frequency of rabies in important wildlife reservoirs during 1999 in the U.S. (adapted from CDC, Krebs et 
al. 2000). 
economic accountability. Cooperation among federal, 
state, county, and municipal agencies with differing 
missions and perspectives in hun place increased 
emphasis on the need for sound communication and 
wordination among partners. The limitation associated 
with only a single licensed oral vaccine (Hanlon and 
Rupprecht 1998) and the spechum of public attitudes 
toward wildlife and rabies control with ORV (Siemer and 
Brown 1994, Meltzer et al. 1997) also contribute to the 
challenge of wildlife rabies control on a large scale. 
Hanlon et al. (1999) discussed the potential 
applicability of passive wildlife rabies surveillance, 
habitat modification, population suppression (local and 
broad scale), contraception, trapvaccinate-release, and 
oral vaccination as rabies control alternatives. While each 
approach may have applicability independently or when 
integrated into a strategy, our discussion will focus on 
ORV during the past decade with the objective of 
providing an update of activities, accomplishments, and 
planning directed toward control of specific te~~estrial 
rabies virus variants in the U.S. 
ORV MECHANISM AND STRATEGIES 
The mechanisms for oral vaccine to immunize 
individual animals essentially involve replication of the 
virus in the animal's mouth (Wandeler 1991). Once the 
immune system is sensitized, immunocompetent 
individuals produce rabies virus neutralizing antibodies, 
which are an effective means of protection against 
productive infection (Orciari et al. 2001, Lamhot et al. 
2m1). -- .-,- 
At the wildlife population level, ORV programs are 
designed to achieve sufficient population (herd) immunity 
to meet rabies control goals. Goals may include 
preventing spread of specific rabies virus variants to new 
geographic areas, reducing the number of positive cases in 
defmed enzootic areas, or eliminating specific variants 
from some or all of their existing range. 
Elimination represents an ideal goal for some rabies 
virus variants, with success depending on a myriad of 
factors. Key factors include: 1) access to safe, effective 
and inexpensive vaccines; 2) availability of attractive, 
target-specific baits; 3) sufficiently sensitive surveillance 
to delineate epizootic rabies fronts, as well as to identify 
rabies foci in e m t i c  areas requiring timely treatment; 4) 
favorable geographic features, such as mountains and 
large bodies of water to help spatially frame ORV 
strategies; 5) dependable and adequate funding to guard 
against administrative failures; and 6) adequate 
documentation and confidence in the anticipated financial 
and social benefits to be derived from specific ORV 
programs. 
Prior to the development and application of 
monoclonal antibodies in the late 1970s (Wiktor and 
Kopowski 1978), rabies was thought to occur as a single 
undifferentiated virus strain. Use of monoclonal 
antibodies has led to the identification of unique rabies 
virus variants adapted to "cycle" within specific wildlife 
species (Smith 1989). This enhanced understanding of 
the dynamics of wildlife rabies has in turn led to 
application of ORV strategies that can be focused on the 
species that act as reservoirs for specific virus variants. 
ORV HISTORY 
Late 1960s to 1994 
The concept of ORV was conceived at the Centers 
for Disease Control and Prevention (CDC) and proven to 
be feasible in the red fox (Baer et al. 1971). Switzerland 
was the first count~y to use oral vaccine in the field in an 
attempt to control rabies in red foxes (Steck et al. 1982). 
Since that time, research has led to the development and 
implementation of ORV programs in several Westem 
European countries (Aubert et al. 1994, Stohr and M e s h  
1996). ORV programs using either attenuate4 rabies 
vaccines or the recombinant Raboral V-RG have 
resulted in several European countries being designated 
free of rabies (Wandeler 2000, ZanoN et al. 2000). 
In North America, the Province of Ontario, Canada 
expanded research during the mid-1970s to evaluate the 
prospect of using ORV to eliminate rabies that became 
established in red foxes in the southem part of the 
Province during the late 1950s (MacInnes and LeBer 
2000). Since 1989, the Ontario Ministry of Natural 
Resources has aerially distributed about 12 million baits 
containing an attenuated rabies virus (EX4 vaccine) that 
has reduced rabies in foxes by more than 97% (MacInnes, 
pers. corn.). 
Although the ability to vaccinate wildlife orally 
against rabies was conceived and first tested under captive 
conditions in the U.S., field application of this technology 
has progressed at a more conservative pace than in 
Europe and Canada. The slower pace at which ORV has 
been embraced in the U.S. may be attributed in part to 
several factors, including a medical system in which the 
monetary costs associated with rabies are often not well 
documented and diffuse, masking the cumulative 
financial impact of wildlife rabies. Although post- 
exposure prophylaxis is relatively expensive at about 
$2,000 (Krebs et al. 1998), access to effective vaccines to 
protect humans who may be exposed, often en masse 
(Noah et al. 1996), and minimize the number of rabies- 
related deaths may create ambivalence toward the need 
for ORV. Philosophical opposition to oral vaccination as 
a prospective wildlife management method for any 
purpose, let alone to achieve improved public health and 
long-term financial savings, likely also has had an effect 
on use of ORV in the U.S. The relatively high costs of 
ORV in the face of competition for resources has 
influenced budgetary support for programs Finally, 
uncertainty of long-term technical success remains a 
concern that can only be removed by the favorable 
outcome of current ORV projects. In spite of a more 
metered enthusiasm for ORV in the U.S., the success of 
early field safety and efficacy trials with V-RG in 
Virginia (Hanlon et al. 1998), Pennsylvania (Hanlon and 
Rupprecht 1998) and New Jersey (Roscoe et al. 1998) 
during the late 1980s and garly 1990s, supported the 
licensing of Rahoral V-RG - the only licensed oral 
vaccine for use in wildlife in the U.S. The commercial 
availab'ity of this vaccine and support for limited 
programs in tum facilitated the initiation of ORV projects 
(Hanlon and Rupprecht 1998) in Ohio (Smith et al. 1999), 
New York (Bigler, pers. comm.; Eidson, pers. comm.), 
Vermont (Bigler, pers. comm.), Maryland (Ho-, pers. 
comm.), Massachusetts (Robhim et al. 1998), Florida 
(Olson et al. WOO) and Texas (Feameyhough et al. 1998) 
that are the building blocks for scientific evaluation and 
refinement for future programs. 
1994 to 2001 
The ORV initiatives that followed the inaugural field 
trials in Virginia, Pennsylvania, and New Jersey were 
undertaken by state or county governments or 
universities, with limited technical and financial support 
provided either by CDC or USDA APHIS Wildlife 
Senices (WS), or a combination from both federal 
sources. With mounting U.S. Congressional support in 
1997, WS received a federal appropriation in FY 1998 to 
participate in cooperative ORV in Texas, Ohio, Vermont, 
and New York uable 1). WS used these resources to 
help meet the needs for each cooperative program, 
including contracting for air services to distribute baits, 
assistance with hand and aerial bait distribution, purchase 
of baits, and providing wildlife management expertise in 
sampling wildlife for post-vaccination evaluation. 
To better ensure strategic ORV planning that would 
lead to greater program stability and effectiveness, WS 
formed a Rabies Management Team in 1997 composed of 
WS operations and research personnel (National Wildlife 
Research Center-NWRC), other APHIS expertise, and 
external expertise from CDC, cooperating states, and 
universities. The team was designed to bring together a 
coalition of expertise from multiple disciplines to 
establish short- and long-term program goals, strategically 
plan to meet those goals, and prioritize research to 
systematically address questions that would contribute to 
enhanced ORV effectiveness. The Rabies Management 
Team meets annually and communicates via conference 
calls and email throughout the year on key issues. 
In 1999, as a result of confirmed index cases of 
raccoon rabies in southern Ontario (Rosatte et al. 2001), 
the threat of raccoon rabies moving south and west 
around the Ohio vaccination barrier, and reduced state 
funding for the gray fox ORV project in Texas (Figure 3), 
WS formulated a funding strategy based on input from 
cooperators to secure additional resources through the 
regular appropriations process as well as from emergency 
sources (Commodity Credit Corporation [CCC] and 
APHIS Contingency Fund). The distribution and spread 
of raccoon variant of rabies, in particular, necessitated this 
action given that states could not succeed independently 
in meeting regional and national rabies control goals. 
Clearly, long-term success of ORV would require 
increased federal support and leadership to bring multiple 
states together in a coordinated strategy. 
Table 1. Recent USDA APHIS Wildlife Services funding 
history for rabies control. 
Federal Funding level 
flscai year ($ millions) Geographic area specified 
1998 1.3, NY, OH, TX, VT 
1999 1.8 NY, OH, TX, VT 
2000 1 .72 NY, OH, TX, VT 
2001 7.13 NY, OH, VT, WV, eastern 
states, TX 
2002 18.3~ NY, OH. VT, WV, eastern 
states, TX, WY 
2003 25.5' NY, OH, VT, WV, eastern 
states, TX, WY 
' includes $225.000 horn the APHIS Contingency 
2 .  Includes $65,000 of APHIS funds 
Includes $4.1 million in Comrnoditv Credit Cornoration funds 
The following recommended course of action was 
pursued by WS in response to feedback from five 
stakeholder meetings held from December 1999 - May 
UMO: 1) expand vaccination zones along the Canadian 
border with New York and Vermont, and to vaccinate for 
the first time the upper Connecticut River Valley between 
Vermont and New Hampshire to contain raccoon variant 
from extending its range northward; 2) extend the current 
Ohio vaccination zone south into West Virginia, tying to 
the Appalachian Mountains to prevent raccoon variant 
form spreading west; and 3) provide additional 
cooperative federal funding to assist Texas in restoring 
the ORV gray fox project to its previous scope. 
Jn response to external cooperator support, WS 
received an increase in appropriated and emergency 
funding through CCC funds to implement the proposed 
ORV expansion to contain raccoon and gray fox rabies 
(Table 1). To conduct these initiatives in 2001, WS 
completed a programmatic environmental assessment to 
comply with the National Environmental Policy Act 
(NEPA) requirements (USDA 2031). Public input 
provided for under NEPA was favorable and the projects 
were completed as proposed (Figure 4). Environmental 
compliance at all levels of government will continue to be 
essential for the operation of long-term ORV programs. 
The establishment of a Memorandum of 
Understanding between the Rabies Section at CDC and 
WS was a key initiative completed in 2000 that is 
designed to enhance cooperation among all parties 
involved or likely to become involved in ORV. 
Fonnaliing this relationship facilitates combing  
wildlife management expertise in WS with the federal 
public health infrastructure already in place at CDC in the 
form of special ORV expertise, epidemiological 
investigation, training, and reference laboratory support 
critical to long-term program success. Interagency 
agreements between CDC and WS are currently in place 
to help augment critical funding needs to meet increasing 
requests for assistance with ORV programs to CDC. 
Given that economic considerations are central to the 
use of ORV for rabies control, WS commissioned a 
broad-based study that was initiated to try to put the high 
costs of ORV in the context of long-term financial 
benefits based on preventing the spread of raccoon rabies 
westward (Kemere et al. 2002). Providing guidance for 
this study was an early undertaking of the Rabies 
Management Team. This study was designed to assess 
the costs and benefits of a scenario-specific ORV strategy 
to contain raccoon rabies from spreading to unaffected 
areas west of the current distribution for raccoon variant. 
The findings from this study were used help formulate 
WS budget requests and proposals. The results of this 
study are encouraging and along with other economic 
studies (Uhaa et al. 1992, Meltzer 1996, Aubert 1999) 
provide a basis for future analvses of increased 
' Includes $6 5 million in ~ornrnod~hl Credlt ~o&ration funds bphistication and sensitivity. ~conomicx will continue to 
Based on projection from the Presidenrs Budget Proposal of be a ccntrd issue to ORV, given that c~nven t i o~d  public 
$13 7 rnllllon Increase 
w 
Figure 3. ORV zones by terrestrial wildlife rabies reservoir species in 2000. 
F i i  4. ORV zones by terrestrial wildlife rabies reservoir species in 2001. 
health approaches in the absence of ORV have succeeded priority. The 2002 WS budget and cooperator resources 
in preventing human rabies deaths. allow for this interim goal to be met through expansion of 
the existing barrier from Lake Erie south to the high 
X I 2  and Beyond mountain of eastem Tennessee (Appalachian Ridge 
Completing ORV that began in 2001 to vaccinate Project). In addition, other important initiatives in 2002 
mountain gaps and other conidors that may facilitate the include: ORV expansion eastward into Pennsylvania, 
spread of raccoon rabies to the west remains the highest continuing efforts in the Northeast, and a full restoration 
Figure 5. Projected ORV zones by terrestrial wildlife resel 
surveillance in Alabama in 2002. 
of the gray fox ORV project in westcentral Texas (Figure 
5). During 2002, about 4.2 million baits are projected to 
be distributed at 75 baitsikm2 in the Appalachian Ridge 
Project. The vaccination zone in Pennsylvania represents 
the largest ORV effort in an area where raccoon rabies 
has been enzootic, as well as the first time baiting will 
occur in a major U.S. metropolitan area- the City of 
Pittsburgh. Post-baiting evaluation will focus on two key 
issues: the relationship of bait uptake and immunity 
(based on serologic titers of virus neutralizing antibodies) 
for a late summer bait drop (time of year), $nd for varying 
bait densities (75, 150, and 300 baitsikm ). The results 
will be compared to previous findings to evaluate optimal 
baiting strategies. 
In anticipation of ORV projects of increasing project 
scope in 2002, the Rabies Management Team has 
established 10 functional teams composed of diverse 
expertise to address critical issues that are integral to 
sound project evolution Qhble 2). Each team is charged 
with evaluating state-of-the-art or science in each area and 
recommending courses of action for the future. 
The Contingency Action Planning Team has 
evaluated practical alternatives to address rabies threats 
that may compromise the integrity of ORV efforts. The 
team is finalizing contingency action recommendations 
that may be taken if: rabies intensifies approaching an 
immure barrier; "hot spots" occur within a barrier; rabies 
breaches a barrier, but is detected just beyond the 
vaccination zone; or if rabies occurs as an isolated focus 
sufticiently distant from a banier to suggest translocation, 
intentional or unintentional, was the source of the focus. 
The Communication Planning Team is developing a 
YOU species and continued enhanced raccoon rabies 
variety of means to enhance interaction with the public on 
ORV, including web site creation. However, an 
immediate charge for this team is to bring together al l  key 
interests including raccoon hunters, dog trainers, 
rehabilitators, nuisance wildlife control operators, and 
agency personnel to seriously address translocation of 
rabies reservoir species, which could jeopardize national 
efforts to control terrestrial variants of rabies. 
Translocation of raccoons from the southeastern U.S. to 
western Virginia and West Virginia in the late 1970s was 
the probable origin of the epizootic mid-Atlantic region 
that had not formerly experienced raccoon rabies (Nettles 
et al. 1979). 
Table 2. Ten interdisciplinary teams charged with 
evaluating critical subject arras integral to effective 
ORV and providing guidance to cooperative rabies 
control planning. 
Contingency Action Planning 
Economic Analysis 
ORV Evaluation 





Baiting StrategiaslGIS Planning 
NEPA Compliance 
Figure 6. Preliminary planning projection for ORV zones by terrestrial wildlife reservoir species in 2003. 
The Economic Analysis Team is providing guidance 
on an analysis of the benefits and costs of a hypothetical 
skunk rabies elimination progam with ORV in Santa 
Barbara County, California. The results of this effort may 
provide a foundation for future statewide and national 
analysis for skunk rabies control. 
The ORV Evaluation Team is formulating 
standardized approaches to assess the integrity of ORV 
efforts. Standardization will make comparisons among 
projects more meaningful. The ability to evaluate project 
progress will hinge heavily on CDC in the form of 
reference laboratory support, testing of surveillance 
samples, serological analysis, and epidemiological 
investigations. In addition, the Surveillance Team has 
recommended that the Rabies Laboratories in New York 
and Virginia provide additional regional support for 
ORV. 
The other teams (Table 2) are focusing on a variety 
of issues, including: new oral vaccines to complement the 
existing recombinant vaccine (Hanlon et al. 2002), NEPA 
analysis for ORV on National Park-managed lands, air 
delivery capability alternatives for the future, and WS and 
external research priorities to close important gaps in ow 
understanding of ORV. 
NWRC scientists began several research initiatives 
in UX)2 designed to enhance ow understanding of ORV 
strategies, rabies reservoir species, and non-target species 
issues. The relationship of bait uptake to bait and target 
species density is a priority project planned for 
Pennsylvania that will allow for comparison to a similar 
study conducted in Ohio in 1999, once those results are 
published. Other studies include: vaccinia (the virus 
vector for rabies glycoprotein in Raboral V - R G ~  
dynamics in captive commensal rodent populations, 
placebo bait preference in skunks in the westem U.S., and 
bait uptake by raccoons in Ohio. WS operations, in 
collaboration with NWRC, will continue to apply its 
raccoon density index protocol and complete a 2-year 
project that began in 2001, designed to assess variation in 
density indices associated with plot size and trapping 
effort. 
The WS Rabies Control Business Plan, 
Progammatic Environmental Assessment for ORV 
(USDA 2001), and Strategic Plan, as well as other 
supporting documentation (e.g., Hanlon et al. 1999) will 
serve as foundation to develop a more comprehensive 
National Rabies Management Plan. This plan will 
provide guidance and recommendations for linking 
regional raccoon rabies control plans, additional 
initiatives to be taken to ensure that ORV technology 
becomes available for use in the field for skunks and 
mongooses, ORV surveillance, and research 
prioritization, as well as other key planning issues. 
The 2003 budget projection for WS looks promising, 
with the President's budget recommending a $13.7 
million increase. Decisions on ORV in Alabama, where 
raccoon rabies appears to now to be slowly spreading 
westward, will be based on enhanced raccoon rabies 
surveillance that has been conducted in Alabama since 
2000. If an ORV zone is justified in Alabama on the 
basis of contemporary enhanced surveillance, it would 
represent the largest new initiative during 2003 (Figure 6). 
Planning and research will continue on prospective baits 
and oral vaccines for us$ in skunks that could also 
complement Raboral V-RG . Effort will also be directed 
toward GIs analysis of baiting strategies that may have 
applicability in terrestrial rabies elimination. Ensuring 
adequate surveillance to measure ORV needs and 
progress will remain a priority. A benefit:cost analysis associations of rabies in rodents and lagomorphs in the 
focusing on the dynamic of raccoon rabies variant United States, 1985-1994. J. Wid. Dis. 33(1):20-27. 
elimination is in the early planning stage and scheduled to m o u c t ~ ,  M. G., P. I. WWN, K A ClARK, D. R 
begjn in 2003. SMIIH, D. H. JOHNSTON, B. N. HICKS, and G. M. MOORE. 
SUMMARY AND CONCLUSIONS 
ORV shows promise as a control method for specific 
rabies virus variants that persist in wildlife reservoirs in 
the U.S. As a result of increased public interest 
manifested through the U.S. Congress, WS received 
increasing federal funding to mperate in and help 
coordinate multi-state efforts to control rabics in 
terrestrial carnivores. In 2001, the ORV zone established 
in Ohio beginning in 1997 was extended southward to 
southern West Virginia to prevent raccoon rabies from 
spreading west and compromising the commitment in 
place in Ohio. The ORV zone will also be extended south 
in 2002 to interface with the high mountains in east 
Tennessee, in an attempt to integrate favorable geographic 
features with the vaccination zone to create a "barrier" at 
reduced cost to prevent raccoon rabies form spreading to 
new areas to the west. Enhanced surveillance currently in 
place in Alabama will provide data on the course of action 
to take from the southern end of the Appalachians to the 
Gulf of Mexico. The cooperative gray fox ORV project 
in west-central Texas has been restored to its original 
schedule through cooperative federal funds and WS 
participation with the Texas Department of Health as the 
iead agency. 
Other key steps being taken with guidance from the 
Rabies Management Team include: ensuring adequate 
surveillance, pursing additional safe and effective oral 
vaccines, conducting priority research to address data 
gaps so that decisions remain science-based, addressing 
translocation of rabics reservoir species near ORV 
projects, and developing and implementing effective 
communication strategies. Economic analysis and NEPA 
compliance have been identified as critical elements of an 
evolving ORV program with national goals and 
objectives. The stability of ORV programs in the near 
tern will be critical to evaluate if such programs can be 
optimized to effectively meet long-term objectives of 
partial or full elimination of specific rabies virus variants 
in terrestrial wildlife reservoirs. 
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